Shouval R, Fein JA, Labopin M, Kröger N, Duarte RF, Bader P, et al. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. Lancet Haematol. 2019;6:e573–e584. https://doi.org/10.1016/s2352-3026(19)30158-9. e-pub ahead of print 2019/09/04

Article  PubMed  Google Scholar 

Petersdorf EW. Mismatched unrelated donor transplantation. Semin Hematol. 2016;53:230–6. https://doi.org/10.1053/j.seminhematol.2016.07.003. e-pub ahead of print 2016/10/30

Article  PubMed  PubMed Central  Google Scholar 

Hwang WY, Kongtim P, Majhail NS, Yao M. Alternate Donor Transplantation. Blood cell Ther. 2022;5:S6–s14. https://doi.org/10.31547/bct-2022-012. e-pub ahead of print 2023/05/23

Article  PubMed  PubMed Central  Google Scholar 

Mushtaq MU, Shahzad M, Tariq E, Iqbal Q, Chaudhary SG, Zafar MU, et al. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis. Front Oncol. 2022;12:1005042. https://doi.org/10.3389/fonc.2022.1005042. e-pub ahead of print 2022/10/25

Nagler A, Dholaria B, Labopin M, Bruno B, Rambaldi A, Pioltelli P, et al. The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. Bone Marrow Transpl. 2021;56:20–29. https://doi.org/10.1038/s41409-020-0974-6. e-pub ahead of print 2020/06/21

Kato I, Sakaguchi H, Kato S, Sato M, Noguchi M, Yoshida N, et al. Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group. Br J Haematol. 2022;199:392–400. https://doi.org/10.1111/bjh.18425. e-pub ahead of print 2022/08/28

Article  CAS  PubMed  Google Scholar 

Crocchiolo R, Rombolà G. Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient-Donor (Mis)matching and New Challenges with the Current Technologies. J Clin Med 2023;12. https://doi.org/10.3390/jcm12020646. e-pub ahead of print 2023/01/22

Arslan S, Al Malki MM. New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT). Hematol Am Soc Hematol Educ Program. 2022;2022:74–82. https://doi.org/10.1182/hematology.2022000398. e-pub ahead of print 2022/12/10

Article  Google Scholar 

Kawamura K. Effect of antithymocyte globulin on HLA-mismatched unrelated transplantation. Int J Hematol. 2019;110:22–9. https://doi.org/10.1007/s12185-019-02597-y. e-pub ahead of print 2019/01/27

Article  CAS  PubMed  Google Scholar 

Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, et al. National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. J Clin Oncol: Off J Am Soc Clin Oncol. 2021;39:1971–82. https://doi.org/10.1200/jco.20.03502. e-pub ahead of print 2021/04/28

Article  CAS  Google Scholar 

Jimenez Jimenez A, Komanduri K, Brown S, Wang T, Pereira D, Goodman M, et al. Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant. Blood Adv. 2022;6:4491–500. https://doi.org/10.1182/bloodadvances.2022007596. e-pub ahead of print 2022/07/07

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2009;15:1628–33. https://doi.org/10.1016/j.bbmt.2009.07.004. e-pub ahead of print 2009/11/10

Article  Google Scholar 

Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions. Lancet Haematol. 2022;9:e919–e929. https://doi.org/10.1016/s2352-3026(22)00293-9. e-pub ahead of print 2022/12/02

Article  CAS  PubMed  Google Scholar 

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2015;21:389–401.e381. https://doi.org/10.1016/j.bbmt.2014.12.001. e-pub ahead of print 2014/12/23

Article  Google Scholar 

Verneris MR, Lee SJ, Ahn KW, Wang HL, Battiwalla M, Inamoto Y, et al. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2015;21:1783–9. https://doi.org/10.1016/j.bbmt.2015.05.028. e-pub ahead of print 2015/06/10

Article  Google Scholar 

Jo T, Arai Y, Kondo T, Mizuno S, Hirabayashi S, Inamoto Y, et al. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients. Cytotherapy. 2022;24:1013–25. https://doi.org/10.1016/j.jcyt.2022.05.009. e-pub ahead of print 2022/06/22

Article  PubMed  Google Scholar 

Arcuri LJ, Hamerschlak N, Rocha V, Bonfim C, Kerbauy MN. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts. Transpl Cell Ther. 2021;27:782.e781–782.e787. https://doi.org/10.1016/j.jtct.2021.06.011. e-pub ahead of print 2021/06/20

Article  CAS  Google Scholar 

Gahrton G, Iacobelli S, Bandini G, Björkstrand B, Corradini P, Crawley C, et al. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica. 2007;92:1513–8. https://doi.org/10.3324/haematol.11353. e-pub ahead of print 2007/11/21

Article  PubMed  Google Scholar 

Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N. Engl J Med. 2001;345:1794–800. https://doi.org/10.1056/NEJMoa011826. e-pub ahead of print 2001/12/26

Article  CAS  PubMed  Google Scholar 

Matsuno N, Wake A, Uchida N, Ishiwata K, Araoka H, Takagi S, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009;114:1689–95. https://doi.org/10.1182/blood-2008-12-194696. e-pub ahead of print 2009/06/19

Article  CAS  PubMed  Google Scholar 

Finke J, Schmoor C, Lang H, Potthoff K, Bertz H. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. J Clin Oncol: Off J Am Soc Clin Oncol. 2003;21:506–13. https://doi.org/10.1200/jco.2003.03.129. e-pub ahead of print 2003/02/01

Article  Google Scholar 

Metheny L, de Lima M. Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis. Expert Rev Hematol. 2019;12:47–60. https://doi.org/10.1080/17474086.2019.1562331. e-pub ahead of print 2018/12/26

Article  CAS  PubMed  Google Scholar 

Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone marrow Transplant. 2014;49:168–73. https://doi.org/10.1038/bmt.2013.107. e-pub ahead of print 2013/07/31

Article  CAS  PubMed  Google Scholar 

Wang Y, Liu QF, Lin R, Yang T, Xu YJ, Mo XD, et al. Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial. Sci Bull. 2021;66:2498–505. https://doi.org/10.1016/j.scib.2021.06.002. e-pub ahead of print 2021/12/30

Article  CAS  Google Scholar 

Luo Y, Jin M, Tan Y, Zhao Y, Shi J, Zhu Y, et al. Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation. Bone marrow Transplant. 2019;54:1668–75. https://doi.org/10.1038/s41409-019-0502-8. e-pub ahead of print 2019/03/15

Article  CAS  PubMed  Google Scholar 

Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, et al. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2009;15:704–17. https://doi.org/10.1016/j.bbmt.2009.02.010. e-pub ahead of print 2009/05/20

Article  CAS  Google Scholar 

Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, et al. Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation. Bone marrow Transplant. 2017;52:1390–8. https://doi.org/10.1038/bmt.2017.153. e-pub ahead of print 2017/07/18

Article  CAS  PubMed  Google Scholar 

Oh H, Loberiza FR Jr, Zhang MJ, Ringdén O, Akiyama H, Asai T, et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood. 2005;105:1408–16. https://doi.org/10.1182/blood-2004-06-2385. e-pub ahead of print 2004/10/16

Article  CAS  PubMed  Google Scholar 

Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, et al. Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2016;22:744–51. https://doi.org/10.1016/j.bbmt.2015.12.027. e-pub ahead of print 2016/01/15

Article  CAS  Google Scholar 

Wang L, Kong P, Zhang C, Gao L, Zhu L, Liu J, et al. Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Ann Hematol. 2023;102:1569–79. https://doi.org/10.1007/s00277-023-05220-7. e-pub ahead of print 2023/04/25

Article  CAS  PubMed  PubMed Central